Nathan C. Bahr, MD

University of Kansas
Kansas City, Kansas, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• LB2303 - Single High-dose of Liposomal Amphotericin B in HIV/AIDS-related Disseminated Histoplasmosis: a Randomized Trial

  Saturday, October 22, 2022
  1:57 PM – 2:09 PM US ET